NL-OMON37499已完成3 期
BEGIN: YOUNG 1, trial id: NN1250-3561. A clinical trial investigating the efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes mellitus. - NN1250-3561
ovo Nordisk0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •-type 1 diabetes mellitus
- •-age: 1 to less than 18 years of age
- •-ongoing daily treatment with insulin for at least three months
- •-HbA1c of 11% or below
排除标准
- •-known or suspected hypersensitivity to trial product
- •-known hypoglycaemic unawareness
- •-more than 1 ketoacidosis requiring hospitalisation within the last 3 months
研究者
相似试验
进行中（未招募）
1 期
Phase I trial - 2021-006930-37The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has endedISRCTN15751828Omeros Corporation (United States)12
进行中（未招募）
1 期
An open-label mass balance study of [14C]NST-6179 in healthy male subjectsIntestinal failure associated liver disease (IFALD), also referred to as parenteral nutrition (PN) associated liver disease, and other potential indications.Digestive SystemISRCTN12367117orthSea Therapeutics B.V.8
已完成
1 期
A study in healthy post-menopausal female volunteers to assess how the test medicine [14C]AZD9833 is taken up, broken down and removed from the bodyER-positive, HER2-negative breast cancerCancerISRCTN46127225AstraZeneca (Sweden)6
进行中（未招募）
1 期
A study to evaluate the effect of itraconazole and carbamazepine on the processing of fenebrutinib by the body in healthy participantsHealthy volunteersISRCTN12005942Genentech32
已完成
1 期
A study to evaluate the effects of multiple doses of itraconazole and carbamazepine on processing of giredestrant by the body in healthy female participantsHealthy female participantsISRCTN16366416Genentech33